Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
Antimicrob Agents Chemother
; 63(8)2019 08.
Article
in En
| MEDLINE
| ID: mdl-31138566
ABSTRACT
Surgical site infections (SSIs) are commonly caused by Staphylococcus aureus We report that a combination of three monoclonal antibodies (MEDI6389) that neutralize S. aureus alpha-toxin, clumping factor A, and four leukocidins (LukSF, LukED, HlgAB, and HlgCB) plus vancomycin had enhanced efficacy compared with control antibody plus vancomycin in two mouse models of S. aureus SSI. Therefore, monoclonal antibody-based neutralization of multiple S. aureus virulence factors may provide an adjunctive perioperative approach to combat S. aureus SSIs.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Staphylococcal Infections
/
Surgical Wound Infection
/
Anti-Bacterial Agents
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2019
Document type:
Article
Affiliation country:
United States